<DOC>
	<DOCNO>NCT02227641</DOCNO>
	<brief_summary>In patient allogeneic stem cell transplantation reactivation latent herpesviruses Cytomegalovirus ( CMV ) Epstein Barr Virus ( EBV ) frequent life threaten complication require antiviral treatment . The underlie problem severe suppression donor immune system transplantation patient . Herpesviruses CMV EBV persist primary infection life long host therefore require constant immunological control . This control largely provide T-cell compartment immune system . After allogeneic stem cell transplantation T-cell compartment require long time reconstitution since small fraction donor T-cells transplant . During time Herpesviruses reoccur due lack effective T-cell control . This study therefore aim reconstitute T-cell compartment CMV EBV specific T-cells early time point allogeneic stem cell transplantation . It mainly phase I study demonstrate vitro generate T-cells apply safely patient population . The study also aim demonstrate efficacy CMV/EBV specific T-cells monitoring viral reactivation use antiviral drug . The hypothesis , CMV/EBV specific T-cell apply safely result graft versus host disease successfully prevent reactivation CMV EBV adoptive transfer patient allogeneic stem cell transplantation .</brief_summary>
	<brief_title>Preventative/Preemptive Adoptive Transfer Peptide Stimulated CMV/EBV Specific T-cells Patients After Allogeneic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<criteria>Indication allogeneic stem cell transplantation HLA identical donor , relate unrelated , 10/10 match Stem cell source : GSCF mobilize peripheral blood stem cell Presence least one HLA allele : A0101 , A0201 , B0702 , B0801 , B3501 , C0702 Positive EBV serology donor Positive CMV serology donor Adequate contraception Donor CMV seronegative Donor EBV seronegative Stem cell source : bone marrow cord blood Alemtuzumab conditioning Sorror Score &gt; 3 Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>CMV</keyword>
	<keyword>Cytomegalovirus</keyword>
	<keyword>EBV</keyword>
	<keyword>Epstein Barr Virus</keyword>
	<keyword>virus</keyword>
	<keyword>T cell</keyword>
	<keyword>adoptive transfer</keyword>
	<keyword>transplantation</keyword>
	<keyword>allogeneic</keyword>
</DOC>